Oric Pharmaceuticals, Inc. — Director's Dealing 2025

Mar 4, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Oric Pharmaceuticals, Inc. (ORIC)
CIK: 0001796280
Period of Report: 2025-03-03

Reporting Person: Kunkel Lori Anne (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-03-03	Common Stock	M	27666	$3.75	Acquired	48166	Direct
2025-03-03	Common Stock	M	20500	$6.33	Acquired	68666	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-03-03	Stock Option (right to buy)	$3.75	M	27666	Disposed	2032-06-16	Common Stock (27666)	Direct
2025-03-03	Stock Option (right to buy)	$6.33	M	20500	Disposed	2033-06-13	Common Stock (20500)	Direct

Footnotes

F1: (A) 20,500 of the shares subject to the option shall vest on the earlier of (i) June 17, 2023 or (ii) the business day prior to the next annual meeting of the Issuer's stockholders that occurs following the date of grant, and (B) one thirty-sixth (1/36th) of the remaining 33,200 shares subject to the option shall vest on each monthly anniversary of June 17, 2022.